Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.
The COVID-19 pandemic presents myriad challenges to hepatologists, gastroenterologists, transplant programs, primary care providers, and, of course, their patients. These frustrations are compounded by the fact that the virus' impact on the liver is not yet fully understood.
In order to advise healthcare providers on how best to serve patients and their families during these unprecedented times, the American Association for the Study of Liver Diseases (AASLD) recently released Clinical Insights for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic. The authors of this freely available resource prefaced it with the disclaimer that it represents only their collective opinions and has not been subjected to the methodical rigor of a practice guideline. Instead, it is a "living" document that will evolve and be updated as new information becomes available.
Nonetheless, it offers valuable clinical recommendations and policies to mitigate the impact of the COVID-19 pandemic on patients with liver disease and the healthcare providers who treat them. Here are some of the takeaways that we have found the most useful at our liver care center.
The Novel Coronavirus' Effects on the Liver: What We Know, What We Don't
New Pandemic Peril? Pretending It's Over as Case Numbers Rise
COMMENTARY
Treating Liver Disease During COVID-19: New Recommendations
William F. Balistreri, MD
DisclosuresMay 14, 2020
Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.
The COVID-19 pandemic presents myriad challenges to hepatologists, gastroenterologists, transplant programs, primary care providers, and, of course, their patients. These frustrations are compounded by the fact that the virus' impact on the liver is not yet fully understood.
In order to advise healthcare providers on how best to serve patients and their families during these unprecedented times, the American Association for the Study of Liver Diseases (AASLD) recently released Clinical Insights for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic. The authors of this freely available resource prefaced it with the disclaimer that it represents only their collective opinions and has not been subjected to the methodical rigor of a practice guideline. Instead, it is a "living" document that will evolve and be updated as new information becomes available.
Nonetheless, it offers valuable clinical recommendations and policies to mitigate the impact of the COVID-19 pandemic on patients with liver disease and the healthcare providers who treat them. Here are some of the takeaways that we have found the most useful at our liver care center.
The Novel Coronavirus' Effects on the Liver: What We Know, What We Don't
Medscape Gastroenterology © 2020 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Treating Liver Disease During COVID-19: New Recommendations - Medscape - May 14, 2020.
Tables
Authors and Disclosures
Authors and Disclosures
Author
William F. Balistreri, MD
Department of Hepatology & Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
Disclosure: William F. Balistreri, MD, has disclosed no relevant financial relationships.